Navigation Links
ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
Date:8/27/2007

/p>

About ImmuneRegen BioSciences, Inc.

IR BioSciences Holdings, Inc., through its wholly owned subsidiary ImmuneRegen BioSciences, Inc., is a development stage biotechnology company focused on the research and development of Homspera(TM) and its derivatives Radilex(TM) and Viprovex(R), which are designed to be used as countermeasures for multiple homeland security bioterrorism threats. Homspera(TM) is derived from Substance P, a naturally occurring peptide immunomodulator and homeostatic compound with the dual effect of improving pulmonary function and the stimulation of the human immune system. For more information, please visit the company's website at http://www.immuneregen.com.

Statements about the Company's future expectations, including statements about the potential for the Company's drug candidates, science and technology, and all other statements in this press release other than historical facts, are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The Company intends that such forward-looking statements be subject to the safe harbors created thereby. These future events may not occur as and when expected, if at all, and, together with the Company's business, are subject to various risks and uncertainties. The Company's actual results could differ materially from expected results as a result of a number of factors, including the fact that preliminary results involved only a small number of test mice, the subsequent investigations were limited in scope, the uncertainties inherent in research and development collaborations, pre-clinical and clinical trials and product development programs, (including, but not limited to the fact that future results or research and development efforts may prove less encouraging t
'/>"/>

SOURCE ImmuneRegen BioSciences, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. ImmuneRegen BioSciences Announces Promising Data on Homspera Suggesting Potential as a Co-Therapeutic Agent
2. Ace Biosciences, Ace393, the Worlds First Commercial Vaccine for Travellers Diarrhoea Caused by Campylobacter Successfully Completes Phase I Clinical Trials
3. The International Myeloma Foundation Says Data Reported at a Global Medical Meeting in Greece Demonstrates Improved Survival for a Wide Range of Myeloma Patients
4. Publication on Pixantrone Preclinical Studies Demonstrates Reduced Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and Mitoxantrone
5. New Research Demonstrates Broad Efficacy of Azixa (MPC-6827) Against Multiple Tumor Types and in Drug Resistant Cell Lines
6. Algeta Demonstrates Targeted Cancer-killing Potential of Novel Alpha Particle Linked Antibodies in Leading Medical Journal Blood
7. Gerons Telomerase Inhibitor Cancer Drug Demonstrates Good Pharmacokinetics and Tolerability in Phase I/II Trial
8. Frova Phase III Study Data Demonstrates That Short-Term Prevention Treatment Reduces Frequency and Severity of Menstrual Migraine
9. Mymetics HIV Vaccine Demonstrates First-Ever Production of Neutralizing IgA Antibodies in Non-Human Primate Model
10. Cipralex demonstrates superiority to duloxetine for acute treatment of depression in new study
11. Newly Published Data Demonstrates Superiority of Cipralex Over Duloxetine for Acute Treatment of Depression
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/17/2010)... loss , ... , ... ... SILVER SPRING, Md. , March 17 The U.S. Food and Drug ...
(Date:3/17/2010)... 20 Leading U.S. Cancer Centers Involved ,, ... , , ... ... HUNTINGTON BEACH, California and ...
(Date:3/17/2010)... BOCA RATON, Fla. , March 17 MedeFile International, Inc. (OTC Bulletin Board: MDFI.OB), leader in portable electronic ... supplemental products, Nation Safe Drivers (NSD), a partnership unparalleled in the field of Personal Health Records(PHR). , ... ... , ...
Breaking Medicine Technology:FDA Approves First Totally Implanted Hearing System 2FDA Approves First Totally Implanted Hearing System 3FDA Approves First Totally Implanted Hearing System 4FDA Approves First Totally Implanted Hearing System 5Agendia to Play Pivotal Role in ISPY-2 Trial for Breast Cancer 2Agendia to Play Pivotal Role in ISPY-2 Trial for Breast Cancer 3Agendia to Play Pivotal Role in ISPY-2 Trial for Breast Cancer 4Agendia to Play Pivotal Role in ISPY-2 Trial for Breast Cancer 5MedeFile Signs Distribution Pact with Roadside Assist Giant NSD 2MedeFile Signs Distribution Pact with Roadside Assist Giant NSD 3MedeFile Signs Distribution Pact with Roadside Assist Giant NSD 4MedeFile Signs Distribution Pact with Roadside Assist Giant NSD 5YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I II TRIAL OF JAK1 JAK2 INHIBITOR CYT387 ENROLLED BY CYTOPIA 14945 1YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I II TRIAL OF JAK1 JAK2 INHIBITOR CYT387 ENROLLED BY CYTOPIA 14945 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I II TRIAL OF JAK1 JAK2 INHIBITOR CYT387 ENROLLED BY CYTOPIA 14945 3YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I II TRIAL OF JAK1 JAK2 INHIBITOR CYT387 ENROLLED BY CYTOPIA 14945 4Accuray Incorporated to Present at Piper Jaffray Healthcare Conference and J P Morgan Small Mid Cap Conference 6489 1Accuray Incorporated to Present at Piper Jaffray Healthcare Conference and J P Morgan Small Mid Cap Conference 6489 2Boston Scientific to Participate in Piper Jaffray Health Care Conference 6487 1
(Date:3/18/2010)... the Cedars-Sinai Heart Institute presented new findings on the ... a drug therapy for atrial fibrillation and the role ... reduction for obese patients with chronic end-stage heart failure ... were made at the American College of Cardiology,s Scientific ...
(Date:3/18/2010)... ... Record (EHR) , ... (PRWEB) March 18, 2010 -- The American Society of Health Informatics Managers, Inc. ... The free application enables Health IT Consultants to help physicians select an Electronic ...
(Date:3/18/2010)... March 18 In its 21-year history, under the ... has trained more than 40,000 teenagers from 170 schools in the ... Los Angeles Marathon. On March 21 , 2,800 SRLA students ... running is the core activity of the program, SRLA,s mission is ...
(Date:3/18/2010)... bowel diseases , ... , , ... ... MEMPHIS, Tenn. , March 18 Scientists report a protein made ...
(Date:3/18/2010)... a health hazard for people over age 50, according to ... Journals of Gerontology Series B: Psychological and Social Sciences ... found that job insecurity increased the chance of harmful effects ... Over time, men reacted with greater physical symptoms, while changes ...
Breaking Medicine News(10 mins):Health News:Cedars-Sinai Heart Institute physicians present findings at ACC scientific meeting 2Health News:Cedars-Sinai Heart Institute physicians present findings at ACC scientific meeting 3Health News:Health IT Consultants: EHR Vendor Directory – There's an App for That 2Health News:Students Run LA Takes 40,000 Students Across the Marathon Finish Line Over Past 21 Years 2Health News:Students Run LA Takes 40,000 Students Across the Marathon Finish Line Over Past 21 Years 3Health News:Study Details Machinery of Immune Protection Against Inflammatory Diseases Like Colitis 2Health News:Study Details Machinery of Immune Protection Against Inflammatory Diseases Like Colitis 3Health News:Study Details Machinery of Immune Protection Against Inflammatory Diseases Like Colitis 4Health News:Study Details Machinery of Immune Protection Against Inflammatory Diseases Like Colitis 5Health News:Looming unemployment harms older workers' health 2
... deficiency, a common hereditary disorder that causes lung and ... and shows signs of being effective, University of Florida ... evaluated the safety of using a so-called gene vector ... deliver a corrective gene to 12 patients who are ...
... that there is a genetic link between SARS in civet ... beings through// civet cats. The results were revealed in the ... research that was carried out in six civet cats, by ... Guangzhou, in cooperation with the university of Hong Kong, matched ...
... enjoying the health and social benefits of participating ... problems related to// over-competitiveness and unrealistic expectations, while ... sport-related injuries in young athletes. The November/December issue ... a special Thematic Issue providing expert viewpoints on ...
... Nestlé has decided to pump in funds to the tune ... the Federal Institute of Technology in Lausanne to invest in ... power of the brain. ,The joint venture, envisaged ... children. Also research to lessen the impact of brain degenerative ...
... have banned the sale of turbot after they detected ... of Beijing’s fish markets, reports the Chinese media. The ... in 1992. ,Due to low resistance to ... sometime leave harmful, carcinogenic residues in their flesh. ...
... AIDS epidemic continues to spiral with 4.3 million new infections ... percent of the cases, states a new UNAIDS report. ... estimates that globally 39.5 million people are living with HIV. ... 960,000 people who became newly infected in the past year. ...
Other Medicine News:Health News:Gene Therapy Shows Promise Against Hereditary Lung Disease 2Health News:Gene Therapy Shows Promise Against Hereditary Lung Disease 3Health News:Kids in Sport—Great for Fitness, but Concern About Injurie 2Health News:Kids in Sport—Great for Fitness, but Concern About Injurie 3Health News:More then Four Million New HIV Infections in 2006: UNAIDS 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: